• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Reduced doses of human papillomavirus vaccine may be effective in preventing condyloma

byCamellia BanerjeeandBrittany Hasty, MD
February 11, 2014
in Chronic Disease, Infectious Disease, Obstetrics, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: CC/Uthman

1. Three doses of the quadrivalent HPV vaccine are best at preventing incidence of condyloma related to HPV 6 or 11. 

2. In women younger than 17 at first vaccination, two doses of vaccine showed considerable reduction in condyloma risk. 

Evidence Rating Level: 2 (Good)            

Study Rundown: Current recommendations for the HPV vaccine include 3-doses given at 0, 2, and 6 months, however, population studies to determine this regimen’s effectiveness are limited. The HPV vaccine is effective in preventing condyloma related to HPV types 6 and 11 and is one of the earliest measurable preventable disease outcomes due to its short intubation time. This study looked at women in Sweden between the ages of 10 and 24 to see first incidence of condyloma in relation to the dosage of vaccine. For first vaccination from ages 10 to 19, three doses of the HPV vaccine was found to be most effective at preventing condyloma. Also, if the first vaccination was between ages 10 and 16, two doses also cause significant reduction in the incidence of condyloma. Because the study was able to use a national population database, there is strength in the population size and the applicability to practice, as often patients do not receive the full course of the vaccine.  Limitations of this study include the possibility of not detecting all condyloma cases if some do not seek medical treatment.  Furthermore, the study does not take into account sexual activity which may be related to the incidence of condyloma.

Click to read the study, published today in JAMA

Relevant Reading: Immunogenicity of Quadrivalent HPV Vaccine Among Girls 11 to 13 Years of Age Vaccinated Using Alternative Dosing Schedules: Results 29 to 32 Months After Third Dose

RELATED REPORTS

Human papillomavirus vaccine effective in preventing infections in the United States

Human Papillomavirus self-sampling may be a culturally-sensitive alternative for Muslim women

Wellness Check: Spirituality

In-Depth [retrospective cohort study]: This study assesses the association between the dose of vaccinations of quadrivalent HPV vaccine and the first incident of condyloma. A total of 1,045,165 females between ages of 10 and 24 were followed up for HPV vaccination and condyloma occurrence. Of those that were vaccinated, 322 cases of condylomas were identified after the vaccine was given, 76 after the first dose, 79 after the second dose and 167 after three doses.  For ages 10 to 16 at first vaccination, compared to those who were unvaccinated the incidence risk ratio (IRR) for condyloma after 3 doses was 0.18 (0.15-0.22, p <0.001), after 2 doses was 0.29 (0.21-0.40, p < 0.001) and after 1 dose 0.31 (0.20-0.49, p < 0.001). In this age group, comparing 2 doses to 1 dose showed little difference (IRR 0.91, 0.52-1.59, p = 0.74) however for 3 doses versus 2 doses, IRR was 0.63 (0.42-0.93, p = 0.02).  For ages 17 to 19 at first vaccination, IRR for 3 versus 2 doses was 0.66 (0.45-0.95, p = 0.03).  Overall, the number of prevented cases with three doses of vaccine compared to two doses in the combined age groups was 66 cases (CI 95%, 23 to 109) per 100,000 person-years.

More from this author: Increased risk of hospitalization following the release of inmates, Terminology used to describe ductal carcinoma in situ impacts patient preferences, Early onset dementia strongly correlated with alcohol intoxication in men, Perceived futility of treatments in the ICU dependent on key patient factors, Worldwide smoking prevalence decreasing as numbers of smokers increase

 

© 2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: condylomahpv
Previous Post

Community health workers improve outcomes in low socioeconomic status patients (IMPaCT)

Next Post

Peer based health education program linked to reduced waist circumference

RelatedReports

Reduced doses of human papillomavirus vaccine may be effective in preventing condyloma
Public Health

Human papillomavirus vaccine effective in preventing infections in the United States

June 23, 2022
Reduced HPV vaccine doses may be adequate
Infectious Disease

Human Papillomavirus self-sampling may be a culturally-sensitive alternative for Muslim women

June 20, 2022
Wellness

Wellness Check: Spirituality

June 21, 2022
Chronic Disease

Imiquimod noninferior to surgery in management of vulvar high-grade squamous intraepithelial lesions

May 17, 2022
Next Post
Gestational weight loss may improve outcomes for obese women

Peer based health education program linked to reduced waist circumference

Preterm birth associated with elevated plasma insulin levels

Preterm birth associated with elevated plasma insulin levels

Classics Series, Landmark Trials in Medicine

Donepezil and vitamin E in Alzheimer’s disease [Classics Series]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Cognitive behavioral therapy efficacious for treatment of comorbid posttraumatic headache and posttraumatic stress disorder symptoms among US veterans
  • Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality
  • Adding atezolizumab to standard of care treatment for human epidermal growth factor receptor 2 (HER2) positive early breast cancer does not improve pathologic response outcomes
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.